What is the Ind-Swift Laboratories Ltd share price today?

The share price of NSE:INDSWFTLAB-EQ on 07 Sep 2026 (as of 10:59:32 IST) is ₹361.95.

What is the NSE:INDSWFTLAB-EQ 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:INDSWFTLAB-EQ 52 week high low range shows a high of ₹389.50 and a low of ₹87.15.

What is the Ind-Swift Laboratories Ltd market cap?

As on 07 Sep 2026, Ind-Swift Laboratories Ltd market cap is ₹3086.27 Cr.

What is the shareholding pattern of Ind-Swift Laboratories Ltd Stock?

The shareholding pattern of Ind-Swift Laboratories Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 42.93% Foreign Institutional Investors (FII): 10.70% Domestic Institutional Investors (DII): 0.17% Mutual Funds: 0% Retail & Others: 46.20% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Ind-Swift Laboratories Ltd?

The Price-to-Earnings (PE) ratio of Ind-Swift Laboratories Ltd is 53.84, and the Price-to-Book (PB) ratio is 0.53, as on 07 Sep 2026.

Ind-Swift Laboratories Share Price

401.25-3.80 (-0.94%)

+286.19% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-0.94%

1 Week

+7.50%

1 Month

+23.70%

3 Month

+99.73%

6 Month

+190.32%

YTD

+355.19%

1 Year

+286.19%

5 Year

+525.98%

10 Year

+965.74%

Max

+2192.86%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

393.60

371.00

320.20

197.10

127.30

87.15

High

419.80

About

Headquartered in Chandigarh, India, Ind-Swift Laboratories Ltd is a public limited company incorporated on January 04, 1995 under the provision of companies Act, 2013. The company is global manufacturer of Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

INDSWFTLABNSE

LTP

1W Low

1W High

Market cap (₹)

1849.9+12.6 (0.69%)

1832.20

1891.50

4,47,476Cr

9602+227 (2.42%)

9312.50

9740

2,54,764Cr

4928.5+88.5 (1.83%)

4848.50

5010

1,89,423Cr

1180.3+20.3 (1.75%)

1152.10

1190.60

1,16,658Cr

1399+4.5 (0.32%)

1364.50

1419

1,11,484Cr

2026.2+72.2 (3.69%)

1963.80

2055.30

1,09,943Cr

2500+199.3 (8.66%)

2303

2504.30

1,01,712Cr

1200.4+15.4 (1.30%)

1185

1222

1,01,005Cr

1716-18 (-1.04%)

1689.30

1740

99,253Cr

2100.7+17.7 (0.85%)

2080

2135

96,031Cr

401.25+28 (7.50%)

371

419.80

3,522Cr

Ind-Swift Laboratories Share Price

401.25-3.80 (-0.94%)

+286.19% past 1 Year

Financial overview

Compounded Sales Growth

10 years0%

5 years-6%

3 years-19%

Last year13%

Compounded Profit Growth

10 years-

5 years-

3 years-3%

Last year-83%

Stock Price CAGR

10 years27%

5 years45%

3 years68%

1 year290%

Return on Equity

10 years9%

5 years19%

3 years29%

Last year3%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
0%	-6%	-19%	13%
-	-	-3%	-83%
27%	45%	68%	290%
9%	19%	29%	3%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

MANKIND

DRREDDY

AUROPHARMA

LUPIN

INDSWFTLAB

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,852	₹447476 Cr	37	12.07	62.82	₹11479 Cr
9,627.5	₹254764 Cr	87.1	34.04	128.41	₹2568 Cr
4,929.5	₹189423 Cr	86.85	16.72	97.06	₹2163 Cr
1,175.1	₹116658 Cr	25.85	9.42	62.53	₹5040 Cr
1,397.3	₹111484 Cr	33.08	9.77	57.87	₹3879 Cr
2,040.2	₹109943 Cr	100.55	6.8	29.25	₹889 Cr
2,482.3	₹101712 Cr	49.79	13.75	71.08	₹1913 Cr
1,200.8	₹101005 Cr	31.35	5.32	63.99	₹4196 Cr
1,724.7	₹99253 Cr	26.73	17.95	96.84	₹3505 Cr
2,094.9	₹96031 Cr	17.37	30.95	154.35	₹5333 Cr
403.6	₹3522 Cr	61.45	2.84	10.22	₹43 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Revaluation reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Trade Payables

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹87 Cr	₹69 Cr	₹59 Cr	₹60 Cr	₹60 Cr	₹60 Cr	₹60 Cr	₹48 Cr	₹46 Cr	₹45 Cr	₹42 Cr	₹42 Cr	₹41 Cr	₹39 Cr	₹38 Cr	₹34 Cr	₹28 Cr	₹25 Cr	₹24 Cr	₹23 Cr
₹92 L	₹74 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹2 Cr	₹2 Cr	₹0	₹0	₹9 Cr	₹9 Cr	₹3 Cr	₹10 Cr	₹5 Cr	₹3 Cr	₹4 Cr	₹2 Cr
₹1296 Cr	₹1030 Cr	₹872 Cr	₹622 Cr	₹541 Cr	₹544 Cr	₹581 Cr	₹540 Cr	₹506 Cr	₹483 Cr	₹476 Cr	₹553 Cr	₹675 Cr	₹805 Cr	₹783 Cr	₹533 Cr	₹416 Cr	₹335 Cr	₹305 Cr	₹287 Cr
₹1296 Cr	₹1030 Cr	₹872 Cr	₹439 Cr	₹345 Cr	₹333 Cr	₹356 Cr	₹300 Cr	₹252 Cr	₹215 Cr	₹192 Cr	₹234 Cr	₹340 Cr	₹455 Cr	₹562 Cr	₹447 Cr	₹325 Cr	₹241 Cr	₹207 Cr	₹186 Cr
₹0	₹0	₹0	₹183 Cr	₹196 Cr	₹211 Cr	₹225 Cr	₹240 Cr	₹254 Cr	₹268 Cr	₹284 Cr	₹319 Cr	₹335 Cr	₹350 Cr	₹222 Cr	₹87 Cr	₹90 Cr	₹94 Cr	₹98 Cr	₹101 Cr
₹1384 Cr	₹1173 Cr	₹931 Cr	₹682 Cr	₹601 Cr	₹604 Cr	₹641 Cr	₹588 Cr	₹553 Cr	₹531 Cr	₹517 Cr	₹595 Cr	₹725 Cr	₹853 Cr	₹824 Cr	₹578 Cr	₹448 Cr	₹363 Cr	₹333 Cr	₹311 Cr
-₹6 L	-₹3 L	-₹2 L	₹0	-₹11 L	-₹9 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹7 Cr	₹3 Cr	₹11 Cr	₹753 Cr	₹848 Cr	₹884 Cr	₹886 Cr	₹954 Cr	₹504 Cr	₹564 Cr	₹667 Cr	₹723 Cr	₹862 Cr	₹757 Cr	₹662 Cr	₹556 Cr	₹480 Cr	₹354 Cr	₹274 Cr	₹263 Cr
₹5 Cr	₹22 Cr	₹0	₹0	₹0	₹0	₹5 Cr	₹12 Cr	₹17 Cr	₹28 Cr	₹79 Cr	₹93 Cr	₹102 Cr	₹63 Cr	₹50 Cr	₹44 Cr	₹108 Cr	₹26 Cr	₹39 Cr	₹28 Cr
-₹50 Cr	-₹45 Cr	-₹32 Cr	-₹30 Cr	-₹52 Cr	-₹60 Cr	-₹78 Cr	-₹79 Cr	-₹96 Cr	-₹106 Cr	-₹29 Cr	-₹5 Cr	₹19 Cr	₹39 Cr	₹41 Cr	₹43 Cr	₹44 Cr	₹48 Cr	₹33 Cr	₹18 Cr
₹7 Cr	₹8 Cr	₹0	₹66 L	₹65 L	₹66 L	₹66 L	₹22 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹23 Cr	₹17 Cr	₹0	₹0	₹0	₹0
₹13 Cr	₹11 Cr	₹1 Cr	₹18 Cr	₹17 Cr	₹16 Cr	₹15 Cr	₹14 Cr	₹13 Cr	₹9 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
-₹18 Cr	₹15 L	-₹19 Cr	₹741 Cr	₹814 Cr	₹840 Cr	₹828 Cr	₹901 Cr	₹438 Cr	₹495 Cr	₹717 Cr	₹811 Cr	₹983 Cr	₹859 Cr	₹777 Cr	₹660 Cr	₹632 Cr	₹427 Cr	₹346 Cr	₹309 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹146 Cr	₹110 Cr	₹94 Cr	₹204 Cr	₹176 Cr	₹139 Cr	₹135 Cr	₹127 Cr	₹129 Cr	₹102 Cr	₹132 Cr	₹134 Cr	₹214 Cr	₹203 Cr	₹254 Cr	₹235 Cr	₹167 Cr	₹149 Cr	₹104 Cr	₹64 Cr
₹105 Cr	₹99 Cr	₹23 Cr	₹106 Cr	₹89 Cr	₹81 Cr	₹73 Cr	₹136 Cr	₹490 Cr	₹497 Cr	₹315 Cr	₹249 Cr	₹21 Cr	₹25 Cr	₹45 Cr	₹18 Cr	₹13 Cr	₹12 Cr	₹15 Cr	₹8 Cr
₹4 Cr	₹6 Cr	₹3 Cr	₹49 Cr	₹64 Cr	₹93 Cr	₹115 Cr	₹93 Cr	₹311 Cr	₹406 Cr	₹504 Cr	₹450 Cr	₹391 Cr	₹422 Cr	₹302 Cr	₹220 Cr	₹0	₹0	₹0	₹0
₹3 Cr	₹6 Cr	₹102 Cr	₹12 Cr	₹5 Cr	₹98 L	₹0	₹31 L	₹6 Cr	₹3 L	₹12 L	₹4,000	₹4 Cr	₹13 Cr	₹18 Cr	₹22 Cr	₹14 Cr	₹9 Cr	₹7 Cr	₹6 Cr
₹257 Cr	₹221 Cr	₹221 Cr	₹371 Cr	₹334 Cr	₹315 Cr	₹323 Cr	₹356 Cr	₹936 Cr	₹1005 Cr	₹951 Cr	₹833 Cr	₹630 Cr	₹663 Cr	₹618 Cr	₹495 Cr	₹194 Cr	₹170 Cr	₹126 Cr	₹77 Cr
₹1623 Cr	₹1394 Cr	₹1133 Cr	₹1794 Cr	₹1749 Cr	₹1758 Cr	₹1792 Cr	₹1845 Cr	₹1927 Cr	₹2031 Cr	₹2185 Cr	₹2239 Cr	₹2339 Cr	₹2376 Cr	₹2219 Cr	₹1733 Cr	₹1274 Cr	₹960 Cr	₹806 Cr	₹698 Cr
₹66 Cr	₹66 Cr	₹1 Cr	₹4 Cr	₹36 Cr	₹40 Cr	₹23 Cr	₹52 Cr	₹99 Cr	₹101 Cr	₹138 Cr	₹174 Cr	₹224 Cr	₹253 Cr	₹345 Cr	₹241 Cr	₹215 Cr	₹169 Cr	₹112 Cr	₹43 Cr
₹18 Cr	₹33 Cr	₹14 Cr	₹852 Cr	₹943 Cr	₹1005 Cr	₹1031 Cr	₹1115 Cr	₹1305 Cr	₹1242 Cr	₹1457 Cr	₹1413 Cr	₹1355 Cr	₹1242 Cr	₹1014 Cr	₹819 Cr	₹588 Cr	₹379 Cr	₹313 Cr	₹291 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹697 Cr	₹652 Cr	₹8 Cr	₹1331 Cr	₹1317 Cr	₹1302 Cr	₹1359 Cr	₹1379 Cr	₹1349 Cr	₹1407 Cr	₹1421 Cr	₹1404 Cr	₹1405 Cr	₹1351 Cr	₹1042 Cr	₹704 Cr	₹598 Cr	₹572 Cr	₹471 Cr	₹394 Cr
₹395 Cr	₹382 Cr	₹3 Cr	₹746 Cr	₹689 Cr	₹563 Cr	₹516 Cr	₹478 Cr	₹425 Cr	₹374 Cr	₹322 Cr	₹287 Cr	₹232 Cr	₹181 Cr	₹132 Cr	₹157 Cr	₹116 Cr	₹78 Cr	₹49 Cr	₹31 Cr
₹302 Cr	₹271 Cr	₹5 Cr	₹585 Cr	₹628 Cr	₹739 Cr	₹843 Cr	₹901 Cr	₹925 Cr	₹1033 Cr	₹1099 Cr	₹1117 Cr	₹1174 Cr	₹1171 Cr	₹910 Cr	₹547 Cr	₹481 Cr	₹494 Cr	₹423 Cr	₹363 Cr
₹10 Cr	₹0	₹0	₹8 Cr	₹9 Cr	₹11 Cr	₹4 Cr	₹13 Cr	₹62 Cr	₹61 Cr	₹78 Cr	₹113 Cr	₹78 Cr	₹161 Cr	₹294 Cr	₹315 Cr	₹173 Cr	₹49 Cr	₹45 Cr	₹21 Cr
₹236 Cr	₹174 Cr	₹111 Cr	₹30 Cr	₹29 Cr	₹36 Cr	₹17 Cr	₹31 Cr	₹31 Cr	₹31 Cr	₹18 Cr	₹18 Cr	₹17 Cr	₹17 Cr	₹17 Cr	₹18 Cr	₹18 Cr	₹18 Cr	₹18 Cr	₹18 Cr
₹236 Cr	₹174 Cr	₹111 Cr	₹30 Cr	₹29 Cr	₹36 Cr	₹17 Cr	₹31 Cr	₹31 Cr	₹31 Cr	₹18 Cr	₹18 Cr	₹17 Cr	₹17 Cr	₹17 Cr	₹18 Cr	₹18 Cr	₹18 Cr	₹18 Cr	₹18 Cr
₹94 Cr	₹81 Cr	₹354 Cr	₹4 Cr	₹4 Cr	₹6 Cr	₹57 Cr	₹57 Cr	₹64 Cr	₹54 Cr	₹69 Cr	₹72 Cr	₹81 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹0	₹0	₹0	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹14 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹646 Cr	₹528 Cr	₹472 Cr	₹630 Cr	₹674 Cr	₹814 Cr	₹929 Cr	₹1009 Cr	₹1088 Cr	₹1202 Cr	₹1264 Cr	₹1319 Cr	₹1350 Cr	₹1351 Cr	₹1223 Cr	₹883 Cr	₹672 Cr	₹560 Cr	₹486 Cr	₹402 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹12 Cr	₹39 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹10 L	₹2 Cr	₹30 Cr	₹45 Cr	₹0	₹0	₹0
₹148 Cr	₹114 Cr	₹10 Cr	₹439 Cr	₹429 Cr	₹376 Cr	₹343 Cr	₹317 Cr	₹317 Cr	₹344 Cr	₹356 Cr	₹348 Cr	₹377 Cr	₹451 Cr	₹494 Cr	₹366 Cr	₹237 Cr	₹205 Cr	₹113 Cr	₹87 Cr
₹199 Cr	₹165 Cr	₹169 Cr	₹505 Cr	₹455 Cr	₹432 Cr	₹396 Cr	₹351 Cr	₹408 Cr	₹357 Cr	₹372 Cr	₹389 Cr	₹444 Cr	₹413 Cr	₹304 Cr	₹294 Cr	₹180 Cr	₹113 Cr	₹105 Cr	₹84 Cr
₹430 Cr	₹425 Cr	₹432 Cr	₹18 Cr	₹21 Cr	₹12 Cr	₹11 Cr	₹30 Cr	₹9 Cr	₹16 Cr	₹23 Cr	₹20 Cr	₹21 Cr	₹18 Cr	₹47 Cr	₹54 Cr	₹54 Cr	₹23 Cr	₹12 Cr	₹12 Cr
₹17 Cr	₹7 Cr	₹0	₹9 Cr	₹17 Cr	₹56 Cr	₹39 Cr	₹42 Cr	₹13 Cr	₹16 Cr	₹13 Cr	₹19 Cr	₹21 Cr	₹27 Cr	₹28 Cr	₹28 Cr	₹45 L	₹50 L	₹100 L	₹80 L
₹172 Cr	₹115 Cr	₹50 Cr	₹192 Cr	₹152 Cr	₹66 Cr	₹74 Cr	₹97 Cr	₹92 Cr	₹95 Cr	₹157 Cr	₹144 Cr	₹126 Cr	₹115 Cr	₹122 Cr	₹79 Cr	₹86 Cr	₹57 Cr	₹87 Cr	₹64 Cr
₹977 Cr	₹865 Cr	₹661 Cr	₹1163 Cr	₹1073 Cr	₹942 Cr	₹863 Cr	₹836 Cr	₹839 Cr	₹829 Cr	₹922 Cr	₹920 Cr	₹989 Cr	₹1025 Cr	₹997 Cr	₹851 Cr	₹603 Cr	₹399 Cr	₹319 Cr	₹248 Cr
₹719 Cr	₹645 Cr	₹440 Cr	₹792 Cr	₹739 Cr	₹627 Cr	₹540 Cr	₹480 Cr	-₹97 Cr	-₹176 Cr	-₹29 Cr	₹87 Cr	₹359 Cr	₹362 Cr	₹379 Cr	₹355 Cr	₹409 Cr	₹229 Cr	₹192 Cr	₹170 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹47,919	₹43 L	₹1 Cr	₹48 Cr
₹1623 Cr	₹1394 Cr	₹1133 Cr	₹1794 Cr	₹1749 Cr	₹1758 Cr	₹1792 Cr	₹1845 Cr	₹1927 Cr	₹2031 Cr	₹2185 Cr	₹2239 Cr	₹2339 Cr	₹2376 Cr	₹2219 Cr	₹1733 Cr	₹1274 Cr	₹960 Cr	₹806 Cr	₹698 Cr
₹159	₹160	₹158	₹84	₹68	₹66	₹70	₹73	₹66	₹58	₹57	₹67	₹93	₹126	₹158	₹141	₹127	₹105	₹96	₹70
₹159	₹160	₹158	₹84	₹68	₹66	₹70	₹73	₹66	₹58	₹57	₹67	₹93	₹126	₹158	₹141	₹127	₹105	₹96	₹70

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
₹62 Cr	₹35 Cr	₹195 Cr	₹113 Cr	₹13 Cr	₹18 Cr	-₹20 Cr	-₹33 Cr	₹38 Cr	-₹50 Cr	-₹68 Cr	-₹91 Cr	-₹109 Cr	-₹105 Cr	₹87 Cr	₹86 Cr	₹50 Cr	₹50 Cr	₹39 Cr	₹24 Cr
-₹20 Cr	-₹37 Cr	₹125 Cr	₹133 Cr	₹226 Cr	₹179 Cr	₹176 Cr	₹186 Cr	₹104 Cr	₹168 Cr	₹186 Cr	₹170 Cr	₹145 Cr	₹112 Cr	₹57 Cr	₹61 Cr	₹59 Cr	₹54 Cr	₹38 Cr	₹36 Cr
-₹103 Cr	-₹20 Cr	-₹483 Cr	-₹51 Cr	-₹88 Cr	-₹62 Cr	-₹31 Cr	-₹215 Cr	-₹68 Cr	-₹22 Cr	-₹39 Cr	₹23 Cr	₹40 Cr	-₹53 Cr	-₹53 Cr	-₹117 Cr	-₹60 Cr	-₹90 L	-₹12 Cr	-₹11 Cr
-₹61 Cr	-₹22 Cr	-₹163 Cr	₹195 Cr	₹150 Cr	₹135 Cr	₹125 Cr	-₹62 Cr	₹73 Cr	₹96 Cr	₹79 Cr	₹102 Cr	₹75 Cr	-₹47 Cr	₹90 Cr	₹30 Cr	₹49 Cr	₹103 Cr	₹65 Cr	₹50 Cr
-₹68 Cr	-₹29 Cr	-₹163 Cr	₹195 Cr	₹150 Cr	₹135 Cr	₹125 Cr	-₹64 Cr	₹73 Cr	₹96 Cr	₹79 Cr	₹98 Cr	₹66 Cr	-₹47 Cr	₹73 Cr	₹18 Cr	₹44 Cr	₹100 Cr	₹57 Cr	₹45 Cr
-₹73 Cr	-₹113 Cr	-₹104 Cr	-₹13 Cr	₹5 Cr	-₹10 Cr	-₹9 Cr	-₹12 Cr	-₹17 Cr	-₹31 Cr	-₹30 Cr	-₹36 Cr	-₹27 Cr	-₹48 Cr	-₹204 Cr	-₹231 Cr	-₹192 Cr	-₹102 Cr	-₹66 Cr	-₹83 Cr
₹142 Cr	₹72 Cr	₹681 Cr	-₹186 Cr	-₹141 Cr	-₹124 Cr	-₹133 Cr	₹100 Cr	-₹62 Cr	-₹69 Cr	-₹48 Cr	-₹64 Cr	-₹38 Cr	₹66 Cr	₹125 Cr	₹214 Cr	₹179 Cr	₹13 Cr	₹10 Cr	₹37 Cr
₹96 L	-₹69 Cr	₹413 Cr	-₹4 Cr	₹14 Cr	₹1 Cr	-₹17 Cr	₹23 Cr	-₹6 Cr	-₹4 Cr	₹2 Cr	-₹94 L	₹38 L	-₹29 Cr	-₹6 Cr	₹4 L	₹31 Cr	₹10 Cr	₹64 L	₹4 L
₹425 Cr	₹494 Cr	₹18 Cr	₹21 Cr	₹12 Cr	₹11 Cr	₹30 Cr	₹9 Cr	₹16 Cr	₹23 Cr	₹20 Cr	₹21 Cr	₹18 Cr	₹47 Cr	₹54 Cr	₹54 Cr	₹23 Cr	₹12 Cr	₹12 Cr	₹12 Cr
₹4 Cr	₹58 L	₹45 L	₹1 Cr	₹0	₹0	-₹2 Cr	-₹2 Cr	-₹38 L	-₹2 Cr	₹0	₹19 L	₹2 Cr	-₹46 L	-₹1 Cr	-₹11 L	-₹9 L	₹53 L	₹0	₹0
₹430 Cr	₹425 Cr	₹432 Cr	₹18 Cr	₹26 Cr	₹12 Cr	₹11 Cr	₹30 Cr	₹9 Cr	₹16 Cr	₹22 Cr	₹20 Cr	₹21 Cr	₹18 Cr	₹47 Cr	₹54 Cr	₹54 Cr	₹23 Cr	₹12 Cr	₹12 Cr

Fundamental Ratios

Consolidated

Standalone

Ind-Swift Laboratories Share Price

401.25-3.80 (-0.94%)

+286.19% past 1 Year

Shareholding summary

Promoters

42.93%

FII

10.7%

DII

0.17%

Others

46.2%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
42.93%	42.99%	39.50%	39.50%	40.94%	40.94%
10.70%	13.88%	14.33%	14.80%	4.27%	3.07%
0.17%	0.00%	0.68%	0.68%	0.91%	0.91%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
46.20%	43.13%	45.49%	45.02%	53.88%	55.08%

Bulk & block deals

Name

Hrti Private Limited

Hcp Investments

Nova Global Opportunities Fund Pcc - Touchstone

Mansi Share And Stock Broking Private Limited

F3 Advisors Private Limited

Share India Securities Limited

D3 Stock Vision Llp

Parth Infin Brokers Pvt Ltd

Sahastraa Advisors Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
29 May 2026	Purchase	10.40 Cr	₹155.10	6.71 L	Bulk	0.771185	NSE
29 May 2026	Sell	3.10 Cr	₹153.04	2.03 L	Bulk	0.233049	NSE
20 Apr 2026	Sell	9.18 Cr	₹131.14	7 L	Bulk	0.804953	BSE
17 Apr 2026	Purchase	11.09 Cr	₹138.07	8.03 L	Bulk	0.923841	NSE
17 Apr 2026	Purchase	10.60 Cr	₹132.66	7.99 L	Bulk	0.918548	NSE
17 Apr 2026	Purchase	9.36 Cr	₹133.25	7.02 L	Bulk	0.807748	NSE
17 Apr 2026	Purchase	9.26 Cr	₹134.28	6.90 L	Bulk	0.79342	NSE
17 Apr 2026	Purchase	6.35 Cr	₹132.38	4.79 L	Bulk	0.551233	NSE
17 Apr 2026	Purchase	6.35 Cr	₹132.76	4.79 L	Bulk	0.550442	NSE
17 Apr 2026	Purchase	6.26 Cr	₹131.74	4.75 L	Bulk	0.546218	NSE

Insider trading & SAST

Client name

Hcp Investments

Essix Biosciences Ltd & Others

Essix Biosciences Limited

Daksh Mehta & Others

Essix Biosciences Ltd & Others

Sunita Jain

Essix Biosciences Limited

S. R. Mehta

Gopal Munjal

Neera Mehta

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
18 May 2026	Other	Disposal	7.5	1.14	0	—	65.03 L	13 Apr 2026 - 17 Apr 2026	Market	9,96,577	SAST	29(2)	—
07 Apr 2026	Promoter	Acquisition	5.88	43.06	0	—	51 L	24 Feb 2026	Pref. Allotment	3,73,34,278	SAST	29(2)	—
02 Mar 2026	Promoter	Acquisition	5.881566	37.92	0	—	51 L	24 Feb 2026	Conversion of security	3,28,82,521	Insider Trading	—	Equity Shares
07 Oct 2025	Promoter	Acquisition	5.53	39.5	0	—	45.15 L	25 Aug 2025	Sch.of Arrangement	3,22,34,278	SAST	29(2)	—
29 Sep 2025	Promoter	Acquisition	5.53	39.5	0	—	45.15 L	25 Aug 2025	Sch.of Arrangement	3,22,34,278	SAST	29(2)	—
28 Aug 2025	Promoter Group	Acquisition	0.333114	0.39	27.19 L	₹10	2.72 L	25 Aug 2025	Scheme of Amalgamation/Merger/Demerger/Arrangement	3,17,960	Insider Trading	—	Equity Shares
28 Aug 2025	Promoter	Acquisition	3.1307	34.04	2.56 Cr	₹10	25.55 L	25 Aug 2025	Scheme of Amalgamation/Merger/Demerger/Arrangement	2,77,82,521	Insider Trading	—	Equity Shares
28 Aug 2025	Promoter	Acquisition	0.374187	0.66	30.54 L	₹10	3.05 L	25 Aug 2025	Scheme of Amalgamation/Merger/Demerger/Arrangement	5,38,980	Insider Trading	—	Equity Shares
28 Aug 2025	Promoter	Acquisition	0.359727	0.43	29.36 L	₹10	2.94 L	25 Aug 2025	Scheme of Amalgamation/Merger/Demerger/Arrangement	3,54,479	Insider Trading	—	Equity Shares
28 Aug 2025	Promoter Group	Acquisition	0.284343	0.59	23.21 L	₹10	2.32 L	25 Aug 2025	Scheme of Amalgamation/Merger/Demerger/Arrangement	4,81,057	Insider Trading	—	Equity Shares

Ind-Swift Laboratories Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Ind-Swift Laboratories Share Price

Ind-Swift Laboratories Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Ind-Swift Laboratories Share Price

Ind-Swift Laboratories Share Price

Oscillators

Moving averages

Ind-Swift Laboratories Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Ind-Swift Laboratories Share Price

Corporate Actions

Company details

Ind-Swift Laboratories Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Ind-Swift Laboratories Share Price

News

Ind-Swift Laboratories sets aggressive FY27 and FY30 revenue, PAT targets

Ind-Swift Labs plans over 400 dossiers filing by FY27 to boost IP revenue

Ind Swift Lab guides FY29 revenue growth to over Rs 1,200 crore

Ind Swift Lab says CDMO partnerships with Viatris, Manx and Arrotex are now operating

Ind Swift Laboratories reports Q1 revenue growth to Rs 191 crores

Ind Swift Laboratories reports sharp rise in quarterly net profit

Ind Swift Laboratories signs Rs 40 crore warehouse agreement in Punjab

Ind-Swift Laboratories posts strong Q4 EBITDA turnaround with double-digit margin

Ind-Swift Laboratories Q4 profit plunges YoY despite healthy revenue growth

Ind-Swift Laboratories Q4 consolidated PBT rises year-on-year despite exceptionals

Ind Swift Laboratories Tribunal Rejects Pi Industries Claims, Confirms No Financial Impact

Ind-Swift Laboratories Plans Rs 40 Crores Capex for Samba Facility Upgrade, Targets Rs 750-800 Crores Sales from FY27-28.

Ind-Swift Laboratories Reports Q3FY26 EBITDA Turnaround to Rs 4.20 Crores, Net Profit Rs 10.74 Crores.

Ind-Swift Laboratories Reports Q3FY26 Consolidated Net Profit of Rs 9.53 Crores vs Loss YoY.

Ind-Swift Laboratories' Derabassi Formulations Facility Receives EU-GMP Compliance Certificate from Hungary Authority.

Ind-Swift Lab Q2 FY25-26 Results: Net Profit, Revenue, EBITDA

Ind-Swift Lab: Q1 Ebitda Gain 3.60 Crores Rupees Vs Loss 6.50 Crores (Yoy) || Q1 Ebitda Margin 2.36%

Ind-Swift Lab: Q1 Cons Net Profit 8.80 Crores Rupees Vs 29.20 Crores (Yoy) || Q1 Revenue 153.00 Crores Rupees Vs 147.00 Crores (Yoy)

Ind-Swift Lab. reports Profit after tax of 8.12 Crores, in the June 2025 quarter

Ind-Swift Lab. - Quaterly Results

Ind-Swift Laboratories Ltd Share Price Today

Ind-Swift Laboratories Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator